PT91803B - Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT91803B
PT91803B PT91803A PT9180389A PT91803B PT 91803 B PT91803 B PT 91803B PT 91803 A PT91803 A PT 91803A PT 9180389 A PT9180389 A PT 9180389A PT 91803 B PT91803 B PT 91803B
Authority
PT
Portugal
Prior art keywords
group
preparation
compounds
adenosine
substituted starting
Prior art date
Application number
PT91803A
Other languages
English (en)
Portuguese (pt)
Other versions
PT91803A (pt
Inventor
James Ray Mccarthy
Esa Tero Jarvi
Michael Louis Edwards
David Martin Stemerick
Nellikunja J Parakash
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PT91803A publication Critical patent/PT91803A/pt
Publication of PT91803B publication Critical patent/PT91803B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052Imidazole radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT91803A 1988-09-27 1989-09-26 Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem PT91803B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US38939189A 1989-08-03 1989-08-03

Publications (2)

Publication Number Publication Date
PT91803A PT91803A (pt) 1990-03-30
PT91803B true PT91803B (pt) 1995-05-31

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91803A PT91803B (pt) 1988-09-27 1989-09-26 Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem

Country Status (18)

Country Link
EP (1) EP0365849B1 (ja)
JP (1) JP2968002B2 (ja)
KR (1) KR0146333B1 (ja)
CN (1) CN1046334A (ja)
AR (1) AR248283A1 (ja)
AT (1) ATE111477T1 (ja)
AU (1) AU621664B2 (ja)
CA (1) CA1336903C (ja)
DE (1) DE68918215T2 (ja)
DK (1) DK171237B1 (ja)
ES (1) ES2063796T3 (ja)
FI (1) FI94763C (ja)
HU (1) HU204843B (ja)
IE (1) IE63561B1 (ja)
IL (1) IL91773A (ja)
NO (1) NO171857C (ja)
NZ (1) NZ230766A (ja)
PT (1) PT91803B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
AU662630B2 (en) * 1992-05-12 1995-09-07 Aventis Inc. A process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
AU784794B2 (en) * 1999-06-09 2006-06-22 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US20040002476A1 (en) * 2002-02-14 2004-01-01 Stuyver Lieven J. Modified fluorinated nucleoside analogues
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
US5047520A (en) * 1987-03-19 1991-09-10 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
DK171237B1 (da) 1996-08-05
CA1336903C (en) 1995-09-05
IE63561B1 (en) 1995-05-17
NO171857B (no) 1993-02-01
AU621664B2 (en) 1992-03-19
DK473289D0 (da) 1989-09-26
AU4176089A (en) 1990-04-05
IE893080L (en) 1990-03-27
JP2968002B2 (ja) 1999-10-25
ATE111477T1 (de) 1994-09-15
EP0365849A3 (en) 1990-12-27
NO893826D0 (no) 1989-09-26
AR248283A1 (es) 1995-07-12
JPH02160769A (ja) 1990-06-20
CN1046334A (zh) 1990-10-24
IL91773A0 (en) 1990-06-10
EP0365849B1 (en) 1994-09-14
ES2063796T3 (es) 1995-01-16
IL91773A (en) 1994-02-27
KR0146333B1 (ko) 1998-08-01
HUT50844A (en) 1990-03-28
HU204843B (en) 1992-02-28
KR900004736A (ko) 1990-04-12
NO893826L (no) 1990-03-28
EP0365849A2 (en) 1990-05-02
FI894546A (fi) 1990-03-28
FI94763C (fi) 1995-10-25
FI94763B (fi) 1995-07-14
NO171857C (no) 1993-05-12
PT91803A (pt) 1990-03-30
DK473289A (da) 1990-03-28
DE68918215T2 (de) 1995-02-02
NZ230766A (en) 1992-07-28
FI894546A0 (fi) 1989-09-26
DE68918215D1 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
DK3040340T3 (en) CHEMICAL COMPOUNDS
JP4531867B2 (ja) 一定のジヌクレオチドおよび粘膜繊毛クリアランスおよび繊毛運動頻度のモジュレーターとしてのそれらの使用
JP3723227B2 (ja) ジ(ウリジン5’)−テトラホスフェート及びその塩の大規模生産のための方法
PT92309B (pt) Processo para a preparacao de novos derivados de 2'-halogenometilideno, 2'-etenilideno e 2'-etinil citidina, uridina e guanosina e de composicoes farmaceuticas que os contem
PT91803B (pt) Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem
NO179710B (no) Nye fosfolipidderivater av nukleosider, og legemiddel inneholdende disse
JP2009062359A (ja) 化学的化合物
PT90080B (pt) Processo para a preparacao de novos derivados acetilenicos, ciano e alenicos de aristeromicina/adenosina
CA2237368C (en) 5'-deoxy-cytidine derivatives
PT90903B (pt) Processo para a preparacao de derivados de (-)-9-{trans-2,trans-3-di-hidroxi-4--(hidroximetil)-ciclopent-4-enil}-adenina
CA2132303A1 (en) Antiviral phosphonic acid derivatives of purine analogues
JP4879398B2 (ja) グリセリルヌクレオチド、それらの製造法および使用
HUT67899A (en) Thioxanthenone antitumor agents
Fleysher et al. Some short-chain N6-substituted adenosine analogs with antitumor properties
JPH02189A (ja) 1‐アミノメチルホスホン酸誘導体、その製造法および医薬組成物
JP2015024981A (ja) 新規なピリミジンヌクレオシド化合物又はその塩
JP3479299B2 (ja) セコ‐ヌクレオシドのリポヌクレオチド、その製法及びその抗ウィルス製剤としての使用
EP0882734A2 (en) 5'-Deoxy-cytidine derivatives
US4935443A (en) N-substituted-3-nitro-4-(ureidooxymethyl)-benzenesulfonamides as radiation enhancers
MXPA98004352A (en) Derivatives of 5'-desoxicitid
MXPA99011769A (en) Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
JPH04356476A (ja) アスコルビン酸誘導体,その製造法および用途

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941121

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040531